Gore Achieves 40 Million Implants Sold Worldwide as it Celebrates 40 Years of Performance
W. L. Gore & Associates, Inc. (Gore) today announced in conjunction with its 40th anniversary, it has sold 40 million devices worldwide. The milestones come as the company showcases its latest innovations and achievements for the vascular community at the 2015 VEITHsymposium® in New York.
The medical products division of Gore was formed by Bill Gore with the intent to design an ideal substitute for a human blood vessel using GORE-TEX® ePTFE. Forty years later, Gore is an industry leader in medical devices with more than 40 million devices sold that are designed to treat patients along the entire length of the body.
At VEITHsymposium 2015, Gore is announcing developments to its diverse portfolio of products, including clinical trial developments, as well kicking off the highly anticipated nominations for the 2016-2017 Pioneers in Performance award.
- The GORE® EXCLUDER® Iliac Branch Endoprosthesis has exceeded 1,000 implants worldwide. This milestone comes only two years after the device received the CE Mark in Europe . The device is currently commercially available in Europe and Australia, in clinical trial in the US, and available through special access in Canada.
- Gore celebrates its 6th year of the Pioneers in Performance Awards by continuing its tradition of honoring physicians responsible for driving medical innovation and improving clinical and patient outcomes. The Pioneers in Performance Awards recognize physicians for their commitment to advancing vascular and endovascular therapy and minimally invasive treatment options for patients across the globe. These specialties include aortic and lower-limb bypass, and dialysis access surgery. The nominees will be announced on Tuesday evening and voting for the 2016 Pioneers in Performance Awards for North America will open beginning on Wednesday, November 18, 2015.
- Global vascular thought leaders will reconvene this week at VEITH for an update on the inaugural Gore-sponsored Surgical Bypass Summit. The group is challenging historic beliefs about surgical bypass and whether there needs to be a change in the current treatment paradigm. Content from the inaugural Surgical Bypass Summit is available at www.surgicalbypass.com .
Gore looks towards the future, continuing to improve lives through advanced materials and delivering meaningful innovations that set the standard of performance.
Now in its 42nd year, VEITHsymposium provides vascular surgeons, interventional radiologists, interventional cardiologists, and other vascular specialists with a unique and exciting format to learn the most current information about what is new and important in the treatment of vascular disease. The 5-day event features rapid-fire presentations from world renowned vascular specialists with emphasis on the latest advances, changing concepts in diagnosis and management, pressing controversies, and new techniques. To register to attend VEITHsymposium, please visit www.VEITHpress.org or contact Pauline T. Mayer at 631.979.3780.
At Gore Medical, we have provided creative therapeutic solutions to complex medical problems for 40 years. During that time, 40 million innovative Gore Medical Devices have been implanted, saving and improving the quality of lives worldwide. Our extensive family of products includes vascular grafts, endovascular and interventional devices, surgical meshes for hernia and soft tissue reconstruction, staple line reinforcement materials, and sutures for use in vascular, cardiac, and general surgery. We are one of a select few companies to appear on all of the U.S. “100 Best Companies to Work For” lists since the rankings debuted in 1984. For more information, visit www.goremedical.com .
Products listed may not be available in all markets. GORE®, GORE-TEX®, and EXCLUDER® are trademarks of W. L. Gore & Associates. AU1143-EN1 NOVEMBER 2015
Chempetitive Group for W. L. Gore & Associates
Andrea Vuturo, +1 (312) 997-2436
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
AURAK22.7.2018 11:54 | pressemeddelelse
AURAK Enters into a Memorandum of Understanding with Al-Farabi Kazakh National University
PHILIP-MORRIS-INTL21.7.2018 20:21 | pressemeddelelse
Philip Morris International Announces Non-Executive Board Chairman Louis Camilleri to Assume CEO Role at Ferrari S.p.A.
LOXAM20.7.2018 16:53 | pressemeddelelse
Loxam Announces a Conditional Agreement to Acquire UK Platforms
SCHLUMBERGER-LIMITED20.7.2018 13:02 | pressemeddelelse
Schlumberger Announces Second-Quarter 2018 Results
FL-H.I.G.-CAPITAL19.7.2018 21:52 | pressemeddelelse
H.I.G. Capital Announces the Sale of KidsFoundation
SIG-COMBIBLOC-GROUP19.7.2018 18:03 | pressemeddelelse
SIG Combibloc Group Holdings S.à r.l.: 2018 Second Quarter Results
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum